0001882782-21-000001.txt : 20211014 0001882782-21-000001.hdr.sgml : 20211014 20211014163412 ACCESSION NUMBER: 0001882782-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211014 DATE AS OF CHANGE: 20211014 EFFECTIVENESS DATE: 20211014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Odyssey Therapeutics, Inc. CENTRAL INDEX KEY: 0001882782 IRS NUMBER: 863384382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-417003 FILM NUMBER: 211323654 BUSINESS ADDRESS: STREET 1: 266 MAIN STREET STREET 2: BUILDING 2, SUITE 11 CITY: MEDFIELD STATE: MA ZIP: 02052 BUSINESS PHONE: (212) 841-1000 MAIL ADDRESS: STREET 1: 266 MAIN STREET STREET 2: BUILDING 2, SUITE 11 CITY: MEDFIELD STATE: MA ZIP: 02052 D 1 primary_doc.xml X0708 D LIVE 0001882782 Odyssey Therapeutics, Inc. 266 MAIN STREET BUILDING 2, SUITE 11 MEDFIELD MA MASSACHUSETTS 02052 (212) 841-1000 DELAWARE None None Corporation true 2021 Gary D Glick 266 MAIN STREET BUILDING 2, SUITE 11 MEDFIELD MA MASSACHUSETTS 02052 Executive Officer Director Carl Gordon 266 MAIN STREET BUILDING 2, SUITE 11 MEDFIELD MA MASSACHUSETTS 02052 Director Jill Carroll 266 MAIN STREET BUILDING 2, SUITE 11 MEDFIELD MA MASSACHUSETTS 02052 Director Valerie Odegard 266 MAIN STREET BUILDING 2, SUITE 11 MEDFIELD MA MASSACHUSETTS 02052 Director Chuck Baum 266 MAIN STREET BUILDING 2, SUITE 11 MEDFIELD MA MASSACHUSETTS 02052 Director Biotechnology Decline to Disclose 06b false 2021-08-30 true true true 0 Indefinite 91629837 Indefinite false 63 0 0 0 false Odyssey Therapeutics, Inc. /s/Gary D. Glick Gary D. Glick President & CEO 2021-10-14